Professional Summary »
Specializing In »
Practice Locations »
Patient Ratings »
Referring Physicians »
Biography
Lisa Zaba M.D. Ph.D., is an Associate Professor of Dermatology, and Director of the Merkel cell carcinoma (MCC) multi-disciplinary clinic and member of the supportive oncodermatology group at the Stanford Cancer Center. She runs a lab focusing on the immunology of MCC and the treatment and prognostic implications of immune checkpoint inhibitor and targeted therapy rashes. Dr. Zaba completed medical school at Cornell University, PhD in immunology at Rockefeller University, Residency and Post-Doc at Stanford University in 2013.
View Full Biography »
Professional Summary
Education & Certifications
- Board Certification: American Board of Dermatology, Dermatology (2013)
- Residency: Stanford School of Medicine (2013) CA
- Internship: Memorial Sloan Kettering Cancer Center Transitional Year Training (2010) NY
- Medical Education: Weill Cornell Medical College (2009) NY
Honors & Awards
- Intern of the Year, Memorial Sloan Kettering Cancer Center (2010)
- Member, Alpha Omega Alpha, Weill Cornell Medical College (2003)
- Recipient, Clinical Translational Science grant for Psoriasis research (2008)
- Recipient, National Dermatology Foundation Award for Scleroderma research (2013)
- Recipient, World Congress scholarship for Psoriasis research (2008)
- Research Scholar, New York Academy of Science (2002)
Administrative Appointments
- Director of Cutaneous Oncology at CCSB, Stanford (2018 - Present)
- Director of MCC Multi-Disciplinary Clinic, Stanford (2021 - Present)
Publications
-
Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1?.
Fiorentino, D. F., Chung, L. S., Christopher-Stine, L., Zaba, L., Li, S., Mammen, A. L., … Casciola-Rosen, L. (2013). Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1?. Arthritis and Rheumatism, 65(11), 2954–62. -
Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position.
Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y., & Greenleaf, W. J. (2013). Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nature Methods, 10(12), 1213–18. -
Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position
Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y., & Greenleaf, W. J. (2013). Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. NATURE METHODS, 10(12), 1213-? -
Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1? antibodies in adults with dermatomyositis.
Fiorentino, D. F., Kuo, K., Chung, L., Zaba, L., Li, S., & Casciola-Rosen, L. (2015). Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1? antibodies in adults with dermatomyositis. Journal of the American Academy of Dermatology, 72(3), 449–55. -
Individuality and variation of personal regulomes in primary human T cells.
Qu, K., Zaba, L. C., Giresi, P. G., Li, R., Longmire, M., Kim, Y. H., … Chang, H. Y. (2015). Individuality and variation of personal regulomes in primary human T cells. Cell Systems, 1(1), 51–61. -
Individuality and Variation of Personal Regulomes in Primary Human T Cells
Qu, K., Zaba, L. C., Giresi, P. G., Li, R., Longmire, M., Kim, Y. H., … Chang, H. Y. (2015). Individuality and Variation of Personal Regulomes in Primary Human T Cells. CELL SYSTEMS, 1(1), 51–61. -
Chromatin Accessibility Landscape of Cutaneous T Cell Lymphoma and Dynamic Response to HDAC Inhibitors.
Qu, K., Zaba, L. C., Satpathy, A. T., Giresi, P. G., Li, R., Jin, Y., … Chang, H. Y. (2017). Chromatin Accessibility Landscape of Cutaneous T Cell Lymphoma and Dynamic Response to HDAC Inhibitors. Cancer Cell. -
Transposition of Native Chromatin for Fast and Sensitive Mulitmodal Analysis of Chromatin Architecture
Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y., & Greenleaf, W. J. (2014). Transposition of Native Chromatin for Fast and Sensitive Mulitmodal Analysis of Chromatin Architecture. BIOPHYSICAL JOURNAL. CELL PRESS. -
Increased Mortality in Black and Asian Patients with Systemic Sclerosis in Northern California
Chung, M., Dontsi, M., Postlethwaite, D., Kesh, S., Zaba, L., & Chung, L. (2018). Increased Mortality in Black and Asian Patients with Systemic Sclerosis in Northern California. ARTHRITIS & RHEUMATOLOGY, 70. -
Increased Mortality in Asians With Systemic Sclerosis in Northern California.
Chung, M. P., Dontsi, M., Postlethwaite, D., Kesh, S., Simard, J. F., Fiorentino, D., … Chung, L. (2020). Increased Mortality in Asians With Systemic Sclerosis in Northern California. ACR Open Rheumatology. -
Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapy.
Nakamoto, R., Zaba, L. C., Rosenberg, J., Reddy, S. A., Nobashi, T. W., Davidzon, G., … Franc, B. L. (2020). Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapy. European Journal of Nuclear Medicine and Molecular Imaging. -
Successful treatment of HIV-negative Kaposi sarcoma with ipilimumab and nivolumab and concurrent management of baseline psoriasis and bullous pemphigoid.
Tabata, M. M., Novoa, R. A., Bui, N. Q., & Zaba, L. C. (2020). Successful treatment of HIV-negative Kaposi sarcoma with ipilimumab and nivolumab and concurrent management of baseline psoriasis and bullous pemphigoid. JAAD Case Reports, 6(5), 447–49. -
Sites of distant metastasis in Merkel cell carcinoma differ by primary tumor site and are of prognostic significance: a population-based study in the Surveillance, Epidemiology, and End Results database from 2010-2016.
Maloney, N. J., Nguyen, K. A., Bach, D. Q., & Zaba, L. C. (2020). Sites of distant metastasis in Merkel cell carcinoma differ by primary tumor site and are of prognostic significance: a population-based study in the Surveillance, Epidemiology, and End Results database from 2010-2016. Journal of the American Academy of Dermatology. -
Imaging Characteristics and Diagnostic Performance of 2-deoxy-2-[18F]fluoro-D-Glucose PET/CT for Melanoma Patients Who Demonstrate Hyperprogressive Disease When Treated with Immunotherapy.
Nakamoto, R., C Zaba, L., Rosenberg, J., Arani Reddy, S., W Nobashi, T., Ferri, V., … Lewis Franc, B. (2020). Imaging Characteristics and Diagnostic Performance of 2-deoxy-2-[18F]fluoro-D-Glucose PET/CT for Melanoma Patients Who Demonstrate Hyperprogressive Disease When Treated with Immunotherapy. Molecular Imaging and Biology. -
Imaging characteristics and diagnostic performance of F-18-FDG PET/CT for melanoma patients who demonstrate hyperprogressive disease when treated with immunotherapy
Nakamoto, R., Zaba, L., Rosenberg, J., Reddy, S., Nobashi, T., Davidzon, G., … Franc, B. (2020). Imaging characteristics and diagnostic performance of F-18-FDG PET/CT for melanoma patients who demonstrate hyperprogressive disease when treated with immunotherapy. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC. -
Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapy
Nakamoto, R., Zaba, L., Rosenberg, J., Reddy, S., Nobashi, T., Davidzon, G., … Franc, B. (2020). Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapy. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC. -
Chromatin accessibility landscapes of skin cells in systemic sclerosis nominate dendritic cells in disease pathogenesis.
Liu, Q., Zaba, L., Satpathy, A. T., Longmire, M., Zhang, W., Li, K., … Chang, H. Y. (2020). Chromatin accessibility landscapes of skin cells in systemic sclerosis nominate dendritic cells in disease pathogenesis. Nature Communications, 11(1), 5843. -
Clinicopathologic characterization of enfortumab vedotin-associated cutaneous toxicity in patients with urothelial carcinoma.
Hirotsu, K. E., Rana, J., Wang, J. Y., Raghavan, S. S., Rieger, K. E., Srinivas, S., … Zaba, L. (2020). Clinicopathologic characterization of enfortumab vedotin-associated cutaneous toxicity in patients with urothelial carcinoma. Journal of the American Academy of Dermatology. -
How we treat Merkel cell carcinoma: within and beyond current guidelines.
Park, S. Y., Doolittle-Amieva, C., Moshiri, Y., Akaike, T., Parvathaneni, U., Bhatia, S., … Nghiem, P. (2021). How we treat Merkel cell carcinoma: within and beyond current guidelines. Future Oncology (London, England). -
Prognostic value of bone marrow metabolism on pretreatment 18F-FDG PET/CT in patients with metastatic melanoma treated with anti-PD-1 therapy.
Nakamoto, R., Zaba, L. C., Liang, T., Reddy, S. A., Davidzon, G., Aparici, C. M., … Franc, B. L. (2021). Prognostic value of bone marrow metabolism on pretreatment 18F-FDG PET/CT in patients with metastatic melanoma treated with anti-PD-1 therapy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. -
Merkel cell carcinoma patients with solid organ transplant or hematologic malignancy: demographics, survival, and prognosticators.
Maloney, N. J., Yang, J. J., & Zaba, L. C. (2021). Merkel cell carcinoma patients with solid organ transplant or hematologic malignancy: demographics, survival, and prognosticators. Journal of the American Academy of Dermatology. -
Response to "Mohs surgery for early-stage Merkel cell carcinoma (MCC) achieves local control better than wide local excision +/- radiation therapy with no increase in MCC-specific death".
Nguyen, K. A., Maloney, N. J., Fonseca, A., Nghiem, P., & Zaba, L. C. (2021). Response to "Mohs surgery for early-stage Merkel cell carcinoma (MCC) achieves local control better than wide local excision +/- radiation therapy with no increase in MCC-specific death". International Journal of Dermatology. -
Drug-induced hypersensitivity syndrome like reaction with angioedema and hypotension associated with BRAF inhibitor use and antecedent immune checkpoint therapy.
Rana, J., Maloney, N. J., Rieger, K. E., Pugliese, S. B., Strelo, J. L., Liu, A., … Kwong, B. Y. (2021). Drug-induced hypersensitivity syndrome like reaction with angioedema and hypotension associated with BRAF inhibitor use and antecedent immune checkpoint therapy. JAAD Case Reports, 13, 147–151. -
Complete remission from intralesional talimogene laherparepvec for regionally advanced Merkel cell carcinoma in an immunocompromised solid organ transplant patient.
Hirotsu, K. E., Hua, V., Tran, A. T., Morris, L., Reddy, S. A., Kwong, B. Y., & Zaba, L. C. (2021). Complete remission from intralesional talimogene laherparepvec for regionally advanced Merkel cell carcinoma in an immunocompromised solid organ transplant patient. JAAD Case Reports, 13, 144–146. -
Prognostic value of lymphovascular invasion in early-stage Merkel cell carcinoma: a retrospective analysis in the National Cancer Database.
Maloney, N. J., Nguyen, K. A., Yang, J. J., & Zaba, L. C. (2021). Prognostic value of lymphovascular invasion in early-stage Merkel cell carcinoma: a retrospective analysis in the National Cancer Database. Journal of the American Academy of Dermatology. -
Histopathologic correlation of skin manifestations of multisystemic inflammatory syndrome in adults (MIS-A) associated with SARS-CoV-2 infection.
So, N. A., So, J., Centkowski, S., Rana, J., Aleshin, M., Kwong, B. Y., … Chiou, A. S. (2021). Histopathologic correlation of skin manifestations of multisystemic inflammatory syndrome in adults (MIS-A) associated with SARS-CoV-2 infection. JAAD Case Reports. -
NUTRITIONAL DEFICIENCY CONTRIBUTING TO REFRACTORY ERYTHRODERMA IN HEMATOPOETIC CELL TRANSPLANT PATIENTS: DISTINCTIVE CLINICAL AND HISTOPATHOLOGICAL FINDINGS.
Winge, M. C., Rieger, K. E., Kim, J., Weng, W.-K., Johnston, L. J., Miklos, D. B., … Kwong, B. Y. (2021). NUTRITIONAL DEFICIENCY CONTRIBUTING TO REFRACTORY ERYTHRODERMA IN HEMATOPOETIC CELL TRANSPLANT PATIENTS: DISTINCTIVE CLINICAL AND HISTOPATHOLOGICAL FINDINGS. Journal of the American Academy of Dermatology. -
Synergistic effect of lymphovascular invasion and nodal involvement on prognosis in Merkel cell carcinoma: a retrospective analysis in the National Cancer Database.
Nguyen, K. A., Maloney, N. J., Yang, J. J., & Zaba, L. C. (2021). Synergistic effect of lymphovascular invasion and nodal involvement on prognosis in Merkel cell carcinoma: a retrospective analysis in the National Cancer Database. Journal of the American Academy of Dermatology. -
Low Expression of the IL-23/Th17 Pathway in Atopic Dermatitis Compared to Psoriasis
Guttman-Yassky, E., Lowes, M. A., Fuentes-Duculan, J., Zaba, L. C., Cardinale, I., Nograles, K. E., … Krueger, J. G. (2008). Low Expression of the IL-23/Th17 Pathway in Atopic Dermatitis Compared to Psoriasis. JOURNAL OF IMMUNOLOGY, 181(10), 7420–7427. -
Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways
Nograles, K. E., Zaba, L. C., Guttman-Yassky, E., Fuentes-Duculan, J., Suarez-Farinas, M., Cardinale, I., … Krueger, J. G. (2008). Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. BRITISH JOURNAL OF DERMATOLOGY, 159(5), 1092–1102. -
Identification of cellular pathways of "Type 1," Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine a in psoriasis
Haider, A. S., Lowes, M. A., Suarez-Farinas, M., Zaba, L. C., Cardinale, I., Khatcherian, A., … Krueger, J. G. (2008). Identification of cellular pathways of "Type 1," Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine a in psoriasis. JOURNAL OF IMMUNOLOGY, 180(3), 1913–1920. -
Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells
Lowes, M. A., Kikuchi, T., Fuentes-Duculan, J., Cardinale, I., Zaba, L. C., Haider, A. S., … Krueger, J. G. (2008). Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 128(5), 1207–1211. -
Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses
Zaba, L. C., Cardinale, I., Gilleaudeau, P., Sulhvan-Whalen, M., Suarez-Farinas, M., Fuentes-Duculan, J., … Krueger, J. G. (2007). Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. JOURNAL OF EXPERIMENTAL MEDICINE, 204(13), 3183–3194. -
Normal human dermis contains distinct populations of CD11c(+)BDCA-1(+) dendritic cells and CD163(+)FXIIIA(+) macrophages
Zaba, L. C., Fuentes-Duculan, J., Steinman, R. M., Krueger, J. G., & Lowes, M. A. (2007). Normal human dermis contains distinct populations of CD11c(+)BDCA-1(+) dendritic cells and CD163(+)FXIIIA(+) macrophages. JOURNAL OF CLINICAL INVESTIGATION, 117(9), 2517–2525. -
A Subpopulation of CD163-Positive Macrophages Is Classically Activated in Psoriasis
Fuentes-Duculan, J., Suarez-Farinas, M., Zaba, L. C., Nograles, K. E., Pierson, K. C., Mitsui, H., … Lowes, M. A. (2010). A Subpopulation of CD163-Positive Macrophages Is Classically Activated in Psoriasis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 130(10), 2412–2422. -
Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis
Zaba, L. C., Fuentes-Duculan, J., Eungdamrong, N. J., Johnson-Huang, L. M., Nograles, K. E., White, T. R., … Krueger, J. G. (2010). Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 125(6), 1261–1268. -
Evaluation of the Psoriasis Transcriptome across Different Studies by Gene Set Enrichment Analysis (GSEA)
Suarez-Farinas, M., Lowes, M. A., Zaba, L. C., & Krueger, J. G. (2010). Evaluation of the Psoriasis Transcriptome across Different Studies by Gene Set Enrichment Analysis (GSEA). PLOS ONE, 5(4), e10247. -
Atopic dermatitis keratinocytes exhibit normal T(H)17 cytokine responses
Nograles, K. E., Suarez-Farinas, M., Shemer, A., Fuentes-Duculan, J., Chiricozzi, A., Cardinale, I., … Guttman-Yassky, E. (2010). Atopic dermatitis keratinocytes exhibit normal T(H)17 cytokine responses. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 125(3), 744–746. -
Dendritic Cells in the Pathogenesis of Sarcoidosis
Zaba, L. C., Smith, G. P., Sanchez, M., & Prystowsky, S. D. (2010). Dendritic Cells in the Pathogenesis of Sarcoidosis. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 42(1), 32–39. -
Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes
Zaba, L. C., Suarez-Farinas, M., Fuentes-Duculan, J., Nograles, K. E., Guttman-Yassky, E., Cardinale, I., … Krueger, J. G. (2009). Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 124(5), 1022–1030. -
IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing T(H)17 T cells
Nograles, K. E., Zaba, L. C., Shemer, A., Fuentes-Duculan, J., Cardinale, I., Kikuchi, T., … Guttman-Yassky, E. (2009). IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing T(H)17 T cells. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 123(6), 1244–1252. -
Resident and "Inflammatory'' Dendritic Cells in Human Skin
Zaba, L. C., Krueger, J. G., & Lowes, M. A. (2009). Resident and "Inflammatory'' Dendritic Cells in Human Skin. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 129(2), 302–308. -
Psoriasis Is Characterized by Accumulation of Immunostimulatory and Th1/Th17 Cell-Polarizing Myeloid Dendritic Cells
Zaba, L. C., Fuentes-Duculan, J., Eungdamrong, N. J., Abello, M. V., Novitskaya, I., Pierson, K. C., … Lowes, M. A. (2009). Psoriasis Is Characterized by Accumulation of Immunostimulatory and Th1/Th17 Cell-Polarizing Myeloid Dendritic Cells. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 129(1), 79–88. -
Risk factors for and prognostic impact of positive surgical margins after excision of Merkel cell carcinoma.
Maloney, N. J., Nguyen, K. A., So, N. A., Aasi, S. Z., & Zaba, L. C. (2021). Risk factors for and prognostic impact of positive surgical margins after excision of Merkel cell carcinoma. Journal of the American Academy of Dermatology. -
Clinical features of drug-induced hypersensitivity syndrome to BRAF inhibitors with and without previous immune checkpoint inhibition: a review.
Maloney, N. J., Rana, J., Yang, J. J., Zaba, L. C., & Kwong, B. Y. (2021). Clinical features of drug-induced hypersensitivity syndrome to BRAF inhibitors with and without previous immune checkpoint inhibition: a review. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. -
Dermatologic toxicities of targeted antineoplastic agents and immune checkpoint inhibitor therapy in pediatric patients: A systematic review.
Liu, L. Y., Teng, J. M., Spunt, S. L., Strelo, J. L., Kwong, B. Y., & Zaba, L. C. (2021). Dermatologic toxicities of targeted antineoplastic agents and immune checkpoint inhibitor therapy in pediatric patients: A systematic review. Pediatric Blood & Cancer, e29346. -
Competing risks analysis of Merkel cell carcinoma with concurrent chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Nguyen, K. A., Maloney, N. J., Yang, J. J., Bach, D. Q., & Zaba, L. C. (2021). Competing risks analysis of Merkel cell carcinoma with concurrent chronic lymphocytic leukemia and non-Hodgkin lymphoma. Dermatology Online Journal, 27(8). -
Efficacy of regional nodal ultrasound surveillance for metastatic detection in sentinel- and complete lymph node dissection-eligible melanoma patients.
Swetter, S. M., Liu, L. Y., Gyurdzhyan, S., & Zaba, L. C. (2021). Efficacy of regional nodal ultrasound surveillance for metastatic detection in sentinel- and complete lymph node dissection-eligible melanoma patients. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Histologic subtype of cutaneous immune-related adverse events predicts overall survival in patients receiving immune checkpoint inhibitors.
Hirotsu, K. E., Scott, M. K., Marquez, C., Tran, A. T., Rieger, K. E., Novoa, R. A., … Zaba, L. C. (2021). Histologic subtype of cutaneous immune-related adverse events predicts overall survival in patients receiving immune checkpoint inhibitors. Journal of the American Academy of Dermatology. -
Yield of sentinel lymph node biopsy in sebaceous carcinoma and predictors of advanced disease: a retrospective analysis of the National Cancer Database.
Maloney, N. J., Nguyen, K. A., So, N. A., & Zaba, L. C. (2022). Yield of sentinel lymph node biopsy in sebaceous carcinoma and predictors of advanced disease: a retrospective analysis of the National Cancer Database. Journal of the American Academy of Dermatology. -
Health Care Utilization and Costs in Systemic Therapies for Metastatic Melanoma from 2016 to 2020.
Qian, M. F., Betancourt, N. J., Pineda, A., Maloney, N. J., Nguyen, K. A., Reddy, S. A., … Zaba, L. C. (2022). Health Care Utilization and Costs in Systemic Therapies for Metastatic Melanoma from 2016 to 2020. The Oncologist. -
The relationship between circulating tumor DNA with Merkel cell carcinoma tumor burden and detection of recurrence.
Akaike, T., So, N., Hippe, D. S., Gunnell, L., Doolittle-Amieva, C., Lachance, K., … Zaba, L. C. (2022). The relationship between circulating tumor DNA with Merkel cell carcinoma tumor burden and detection of recurrence. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Risk factors for and prognostic impact of positive surgical margins after excision of Merkel cell carcinoma
Maloney, N. J., Nguyen, K. A., So, N. A., Aasi, S. Z., & Zaba, L. C. (2022). Risk factors for and prognostic impact of positive surgical margins after excision of Merkel cell carcinoma. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 87(2), 444–446. -
Utility of a circulating tumor DNA test for detecting clinically evident and occult Merkel cell carcinoma
Akaike, T., So, N., Hippe, D. S., Gunnell, L., Doolittle-Amieva, C., Lachance, K., … Zaba, L. C. (2022). Utility of a circulating tumor DNA test for detecting clinically evident and occult Merkel cell carcinoma. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC. -
Impact of duration of immunotherapy on clinical outcomes in advanced Merkel cell carcinoma patients responding to first-line immunotherapy
Tachiki, L. M., Zawacki, L., Hippe, D. S., Moshiri, Y., Alexander, N., Akaike, T., … Nghiem, P. (2022). Impact of duration of immunotherapy on clinical outcomes in advanced Merkel cell carcinoma patients responding to first-line immunotherapy. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC. -
In Patients with Advanced Urothelial Carcinoma, Immune Checkpoint Inhibition Prior to Enfortumab Vedotin Is Associated with High-grade Skin Toxicity.
Molina, G. E., Schwartz, B., Srinivas, S., Shah, S., & Zaba, L. C. (2023). In Patients with Advanced Urothelial Carcinoma, Immune Checkpoint Inhibition Prior to Enfortumab Vedotin Is Associated with High-grade Skin Toxicity. European Urology. -
Utility of a circulating tumor DNA test for detecting clinically evident and occult Merkel cell carcinoma
Akaike, T., So, N., Hippe, D. S., Gunnell, L., Doolittle-Amieva, C., Lachance, K., … Zaba, L. C. (2022). Utility of a circulating tumor DNA test for detecting clinically evident and occult Merkel cell carcinoma. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC. -
Impact of duration of immunotherapy on clinical outcomes in advanced Merkel cell carcinoma patients responding to first-line immunotherapy
Tachiki, L. M., Zawacki, L., Hippe, D. S., Moshiri, Y., Alexander, N., Akaike, T., … Nghiem, P. (2022). Impact of duration of immunotherapy on clinical outcomes in advanced Merkel cell carcinoma patients responding to first-line immunotherapy. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC. -
Online risk calculator and nomogram for predicting sentinel lymph node positivity in Merkel Cell Carcinoma.
Maloney, N. J., Aasi, S. Z., Kibbi, N., Hirotsu, K. E., & Zaba, L. C. (2023). Online risk calculator and nomogram for predicting sentinel lymph node positivity in Merkel Cell Carcinoma. Journal of the American Academy of Dermatology. -
Development of a Skin-Directed Scoring System for Stevens-Johnson Syndrome and Epidermal Necrolysis: A Delphi Consensus Exercise.
Waters, M., Dobry, A., Le, S. T., Shinkai, K., Beachkofsky, T. M., Davis, M. D., … Kaffenberger, B. H. (2023). Development of a Skin-Directed Scoring System for Stevens-Johnson Syndrome and Epidermal Necrolysis: A Delphi Consensus Exercise. JAMA Dermatology. -
Immunotherapy for keratinocyte cancers. Part II: Identification and management of cutaneous side effects of immunotherapy treatments.
Chang, A. L., Zaba, L., & Kwong, B. Y. (2023). Immunotherapy for keratinocyte cancers. Part II: Identification and management of cutaneous side effects of immunotherapy treatments. Journal of the American Academy of Dermatology, 88(6), 1243–1255. -
Anti-cancer therapy related hand-foot syndrome in patients with systemic sclerosis: Case series and literature review
Grinnell, M., Rieger, K. E., Katsumoto, T. R., Kwong, B. Y., & Zaba, L. C. (2020). Anti-cancer therapy related hand-foot syndrome in patients with systemic sclerosis: Case series and literature review. CURRENT PROBLEMS IN CANCER: CASE REPORTS, 1. -
Anti-Cancer Therapy Related Hand-Foot Syndrome in Patients with Systemic Sclerosis: Case Series and Literature Review (vol 1, 100021, 2020)
Grinnell, M., Rieger, K. E., Katsumoto, T. R., Kwong, B. Y., & Zaba, L. C. (2021). Anti-Cancer Therapy Related Hand-Foot Syndrome in Patients with Systemic Sclerosis: Case Series and Literature Review (vol 1, 100021, 2020). CURRENT PROBLEMS IN CANCER: CASE REPORTS, 3. -
Association of histopathological grade with stage and survival in sebaceous carcinoma: a retrospective cohort study in the National Cancer Database.
Maloney, N. J., Zacher, N. C., Aasi, S. Z., Hirotsu, K. E., Zaba, L. C., & Kibbi, N. (2023). Association of histopathological grade with stage and survival in sebaceous carcinoma: a retrospective cohort study in the National Cancer Database. Journal of the American Academy of Dermatology. -
Risk of Multiple Primary Cancers in Patients With Merkel Cell Carcinoma: A SEER-Based Analysis.
Eid, E., Maloney, N. J., Cai, Z. R., Zaba, L. C., Kibbi, N., John, E. M., & Linos, E. (2023). Risk of Multiple Primary Cancers in Patients With Merkel Cell Carcinoma: A SEER-Based Analysis. JAMA Dermatology.
Practice Locations
Skin Cancer Program in Palo Alto Palo Alto, CA
Palo Alto, CA
Skin Cancer Program in Palo Alto
900 Blake Wilbur Drive, 3rd Floor
Palo Alto , CA 94304
Make An Appointment More Clinic Information » Getting Here »Supportive Dermato-Oncology Program Palo Alto, CA
Palo Alto, CA
Supportive Dermato-Oncology Program
900 Blake Wilbur Drive, 3rd Floor
Palo Alto , CA 94304
Make An Appointment More Clinic Information » Getting Here »Stanford Pigmented Lesion and Melanoma Program at Stanford Cancer Center Palo Alto Palo Alto, CA
Palo Alto, CA
Stanford Pigmented Lesion and Melanoma Program at Stanford Cancer Center Palo Alto
900 Blake Wilbur Drive, 3rd Floor
Palo Alto , CA 94304
Make An Appointment More Clinic Information » Getting Here »Skin Cancer Program in San Jose San Jose, CA
San Jose, CA
Skin Cancer Program in San Jose
2589 Samaritan Drive
San Jose , CA 95124
Make An Appointment More Clinic Information » Getting Here »Stanford Pigmented Lesion and Melanoma Program at Stanford Cancer Center South Bay San Jose, CA
San Jose, CA
Stanford Pigmented Lesion and Melanoma Program at Stanford Cancer Center South Bay
2589 Samaritan Drive
San Jose , CA 95124
Make An Appointment More Clinic Information » Getting Here »Important Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Patient Reviews
(81 reviews)
Love Dr. Zaba
Dr. Zaba is very competent and warm and friendly. She discussed all areas I was hoping for.
Dr. Zaba is very caring, personal and informative. We enjoy talking to her and her staff.
Excellent doctor!!! I have always felt I was always cared for. She never leaves a stone unturned. Wants to make sure I am free from the disease or she will continue to care for me if the disease process lasts the rest of my life. Have always felt supported.
Dr Zaba is outstanding!
She is a good doctor
Dr. Zaba is a wonderful doctor and person. She made herself available for an appointment to address a reaction I had to a new medication. She knew exactly what was happening and knew how to treat it. I am so grateful to have her on my care team. Her nursing staff is exceptionally helpful and supportive as well.
very nice and informative about my condition.
Dr Zaba is the best!
I wrote in the previous screen that Dr Zaba is a terrific person and professional- she cares, listens, and is an expert in her field. She is a great support to me. My heartfelt thanks to her and her entire team for helping to manage through this difficult journey! She’s making a difference in my health.
She was very professional.
Love my doctors and health team!
Dr. Zaba is great!! Her suggestions for my issue started working within a day. There was no visible component to my issue, so a video visit was excellent.
She is great!
Dr. Zaba is always enthusiastically committed to my dermatology concerns!
Everything went well, but later I realized I came away without asking the questions I needed to ask. I was given the opportunity to ask, but it was not until I exited the appointment that I realized the were several Al topics e he not covered
Dr. Zaba is really enthusiastic. She knows her subject well, and particularly knows my specific dermatologic problems and was able to give me good, pertinent information to deal with it.
Thanks.
Excellent doctor. Answered all my questions and gave some excellent advise for my treatments.
Very courteous & professional. Excellent bedside manner.
She is an excellent doctor.
Great experience. Many thanks.
Dr. Zaba is knowledgeable, attentive, professional and approachable.
Zaba and her team make you feel safe and important
Grateful for you and your staff's care of me!
Excellent care.
Love Dr. small very impressed, looking forward to working with him.
I would definitely recommend Dr. Zaba..
Thank you for the video visit
Dr zaba is a gifted doctor!
very efficient and helpful
Very appreciative of her time and help.
Excellent team
Visit was very good
very good appointment. Fast and efficient
Very accommodating when scheduling around my tight work schedule.
Always a good experience
Dr. Zaba was friendly, knowledgeable and kind. I had a great experience with her.
Dr. Zaba was professional, personable and knowledgeable. She listened and heard my concerns and had viable responses.
So far everything is great thank you!
Dr Zeba is very knowledgeable and professional.
She’s great
She is thorough and warm. Very easy to work with.
Excelant
She put us at ease, and we confident to be in her care
Attentive and passionate about working toward solutions.
Smart and polite, easy to understand.
Dr.Zaba and Gabe are EXCELLENT! Always make me feel heard and are always trying to help in anyway!
As always, thank you Dr.Zaba and Gabe! You both are wonderful!!
Very personable, Explained the examination well.
Lisa is an outstanding and compassionate clinician
Dr Zaba takes my worries away. Always leave the room with a smile and feeling better.
Dr.Zaba and Dr.Molina are wonderful! They listen and try to come up with solutions for any issue you mention!
Dr. Zaba provided excellent information and understandable for me and my options. She was friendly and answered my questions clearly
I typed what I wanted to say in the previous comment page. I want to reiterate that I highly recommend Dr. Zaba because of her expertise and her positive suggestions to my health issues snd concerns.
She is brilliant, extraordinarily competent, and an outstanding communicator, kindly and one of the best of the best physicians!!!
Dr Zaba was very knowledgeable, encouraging and very nice
Explains things very well
Excellent provider!
Dr. Zaba and her team are excellent.
Dr Zaba is a great doctor. I can feel her passion of being a doctor and the passion is very contagious. And she is very persuasive when educating the patient, me.
Dr Zaba is an excellent doctor and explained instructions thoroughly so there’s no confusion. Very professional
She explained everything very clear and answered all my questions. I feel confident to see her.
She is a very good dermatologist and has been helpful in countering some of the skin related side effects of the daily drug I am taking for my lung cancer. I would strongly recommend her to anyone going through the same thing.
Dr. Zaba is an excellent physician, and I would recommend her to my family and friends.
Dr. Zaba is very methodical in her approach to my care and includes me in her decision making. She has an excellent presentation in her verbal delivery and instills confidence in her patients.
Liza Zaba is a very professional yet compassionate doctor. She listens very well and she had some suggestions that I will follow through with. She also had things she was doing for me snd we agreed to correspond through Stanford My Health. She also set up a future appointment for me but assured me if I needed her, I would be able to get in touch with her. I was very pleased with today’s appointment and with her knowledge of the targeted drug I’m on.
Dr. Zaba is outstanding - Brilliant, caring, knowledgeable.
Both resident & derm. MD (Zaba) - very good.
Dr. Zaba = the best!!!
I think they spent the time needed to keep me informed.
I was impressed with the unhurried time the care team spent with me!
All the people PA's, Drs., were very knowledgeable thoughtful, caring, and did a great job of teaching us & sharing what would be done.
All good!
Dr. Lisa engaging, informative, "love her."
Dr. Zaba was wonderful.
conscientious and very informed of the recent developments in the cancer
Dr. Zaba is my favorite of all my doctors. She is the only one who I honestly believe understand how terrifying my diagnosis has been for me.
Loved her! Great energy and clearly love her job.
Dr. Zaba was able to make an "undignified body rash check" into something I was at ease with - WELL DONE!
I have a rare disease so collaboration is key.
Very knowledgeable about my prior medical history on paperwork she received which made for a quick & to the point visit.
View More »
Referring Physicians
PHYSICIAN HELPLINE
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records